期刊文献+

沙格列汀联合地特胰岛素治疗老年2型糖尿病的疗效观察 被引量:2

Observation on effect of Shah Glenn Dean combined with insulin detemir therapy in elderly type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨沙格列汀联合地特胰岛素在老年2型糖尿病治疗中的疗效。方法:选取80例糖尿病患者作为观察对象,按照入院先后顺序分为对照组与观察组各40例,对照组给予甘精胰岛素(Gla)治疗,观察组给予沙格列汀联合地特胰岛素(Det)治疗,对比治疗后两组患者的空腹血糖(GLU)、餐后2h血糖(2 h PBG)及低血糖发生率。结果:治疗后,观察组的GLU、2 h PBG均有明显改善,均具有统计学意义(P<0.05),两组低血糖发生率比较,差异无统计学意义(P>0.05)。结论:沙格列汀联合地特胰岛素可以有效改善老年2型糖尿病的GLU、2 h PBG水平,改善临床症状。 Objective To investigate the curative effect of Shah Glenn Dean combined with insulin detemir in elderly in type :2 diabetes mellitus patients. Method 80 eases of diabetic patients were selected as observation objects,in accordance with the order of admission were randomly divided into control group and observation group with 40 cases in each group, the control group were given insulin glargine (Gla) treatment,the observation group was given the Shah Glenn Dean combined detemir insulin treatment (Det), fasting blood glucose two groups were compared after treatment (GLU) and 2 h postprandial blood glucose (2 h PBG) and the incidence of hypoglycemia. Results After the treatment ,the observation group GLU ,2 hPBG were obviously improved, and significantly better than the control group ,with statistical signifi- cance ( P 〈 0. 05 ), and the incidence of hypoglycemia with no significance (P 〉 0. 05 ). Conclusion Shah Glenn Dean combined with insulin detemir can effectively improve the elderly patients with type 2 diabetes GLU,2 h PBG level,improve the clinical symptoms.
作者 武金文 华燕
出处 《吉林医学》 CAS 2015年第14期2998-2998,共1页 Jilin Medical Journal
关键词 糖尿病 沙格列汀 地特胰岛素 Diabetes mellitus Shab Glenn Dean insulin detemir
  • 相关文献

参考文献3

二级参考文献35

  • 1Porcellati F, Rossetti P, Busciantella NR, et al. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes[J]. Diabetes Care, 2007, ( 30 ) :2447 - 2452.
  • 2Miles HL, Acerini CL. Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus [ J ]. Pediatr Drugs,2008,10 (3) :163 -176.
  • 3Crasto W,Jarvis J, Khunti K, et al. New insulins and new insulin regimens:a review of their role in improving glycaemic control in patients with diabetes [ J ]. Postgrad Med J,2009,85:257 - 267.
  • 4Rosenstock J, Davies M, Home PD, et al. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulinnaive people with type 2 diabetes [ J ]. Diabetologia, 2008 ( 51 ) : 408 -416.
  • 5Rossetti P, Pampanelli S, Fanelli C,et al. Intesive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime[J]. Diabetes care,2003,26:1490 - 1496.
  • 6Peterson GE. Inter mediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir [ J ]. Curt Med Res Opin,2006,22 (12) :2613 - 2619.
  • 7Riddle MC, Rosenstock J, Gerieh J, et al. The treat-to-target trial, randomized addition of glargine or human NPH insulin ro oral therapy of type 2 diabetic patients [ J ]. Diabetes Care, 2003 (26) :3080-3086.
  • 8Vague P,Selam JL, Skeie S, et al. Insulin determir is associated with more predictable glycemJc control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart [ J ]. Diabetes Care,2003 (26) :590-596.
  • 9Johnson CK. When a unit of insulin is not a unit:Determir dosing and insulin cost in type 2 diabetes mellitus [ J ]. Insulin, 2009,4: 87 - 93.
  • 10Soliman AT, Omar M, Rizk MM, et al.Glycaemic control with modified intensive insulin injuctions (MII) using insulin pens and premixed insulin in children with type 1 diabetes:a randomized controlled trial [ J 1. J Trop Pediatr, 2006,52:276 - 281.

共引文献46

同被引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部